Global Viral Gastroenteritis Market Outlook 2025-2034: Trends, Innovations, And Future Outlook

The Viral Gastroenteritis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Viral Gastroenteritis Market Size and Its Estimated Growth Rate?
There has been a consistent expansion in the viral gastroenteritis market in the last few years. It is projected to surge from $6.75 billion in 2024 to $7.08 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.0%. Factors that have led to this growth in the historic period include the prevalence of viral infections, improvements in global hygiene habits, advancements in diagnostic methods, the increase in worldwide travel and tourism, and changes in climate and environmental conditions.

The market size of viral gastroenteritis is anticipated to exhibit robust expansion in the upcoming years, reaching a value of $8.73 billion by 2029, with a compound annual growth rate (CAGR) of 5.4%. The predicted growth within this period is primarily due to improvements in global health readiness, the implications of climate change, the adoption of a one health approach, enhancements in epidemiological surveillance systems, and increased education and public awareness. Some emerging trends within this period consist of developing vaccines, sophisticated diagnostics, usage of telemedicine in diagnosis, combined research initiatives, techniques focusing on personalized medicine and deploying digital health solutions.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12127

How Are Emerging Segments Shaping the Viral Gastroenteritis Market Landscape?
The viral gastroenteritis market covered in this report is segmented -

1) By Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs
2) By Diagnosis: Physical Examination, Rapid Stool Test
3) By Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications
4) By Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus
5) By End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users

Subsegments:
1) By Antibiotics: Broad-Spectrum Antibiotics, Narrow-Spectrum Antibiotics, Penicillins, Macrolides, Cephalosporins
2) By Antacids: Proton Pump Inhibitors (PPIs), Histamine-2 Receptor Antagonists (H2 Blockers), Magnesium-Based Antacids, Calcium-Based Antacids, Sodium Bicarbonate
3) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners
4) By Antimotility Agents: Loperamide, Diphenoxylate
5) By Other Drugs: Oral Rehydration Salts (Ors), Zinc Supplements, Antiemetics

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12127&type=smp

Which Growth Factors Are Influencing Viral Gastroenteritis Market Expansion?
The rise in gastrointestinal disorders is anticipated to boost the viral gastroenteritis market's expansion. Gastrointestinal (GI) disorders are diseases that affect any part of the gastrointestinal tract. Drugs and diagnosis treatments for viral gastroenteritis provide adequate medication to those afflicted by the disease. For example, the Impact of IBD Report 2023, issued by the IBD Clinical and Research Centre, a Canada-based organization committed to enhancing the quality of life for patients with Crohn's disease and ulcerative colitis, stated in September 2023 that the prevalence rate stood at 825 per 100,000 in 2023, with over 320,000 Canadians suffering from inflammatory bowel disease (IBD). The report projected, with an expected increase in prevalence by 2.44% annually, by 2035, 470,000 Canadians or 1.1% of the population would be living with IBD. Consequently, the escalating prevalence of gastrointestinal disorders is fueling the expansion of the viral gastroenteritis market.

Who Are the Dominant Players Across Different Viral Gastroenteritis Market Segments?
Major companies operating in the viral gastroenteritis market include Pfizer Inc., Abbvie Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, C.H. Boehringer Sohn AG & Co. KG, Mylan N.V., Astellas Pharma Inc., Fresenius Kabi AG, Bausch Health Companies Inc., Alexion Pharmaceuticals Inc., Horizon Therapeutics Plc, Dr. Reddy's Laboratories Ltd., BioMarin Pharmaceutical Inc., Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd, Ironwood Pharmaceuticals Inc, ANI Pharmaceuticals Inc., Merck Sharp & Dohme Corp., Allergan plc, Haustus Biotech Private Limited, Gracia Lifesciences India Private Limited

What Are the Latest Developing Trends in the Viral Gastroenteritis Market?
The focus on product innovation is a major trend emerging in the viral gastroenteritis market. Core firms functioning in this market are emphasizing the creation of new products to solidify their market standing. For example, in November 2022, GlaxoSmithKline PLC, a British biopharmaceutical corporation, gained approval from the US Food and Drug Administration (FDA) for their oral-dosing applicator-only presentation (liquid formulation) of ROTARIX, intended for preventing rotavirus gastroenteritis in infants. The convenience of this new formulation for healthcare providers is augmented by eliminating the necessity for the reconstitution of the vaccine dose at the point of use. The approval draws support from global clinical trial data that exhibits safety, tolerability compared to the lyophilized formulation, and non-inferior immunogenicity.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report

Which Geographic Regions Are Expected to Dominate the Viral Gastroenteritis Market in the Coming Years?
North America was the largest region in the viral gastroenteritis market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral gastroenteritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Viral Gastroenteritis Market?
2. What is the CAGR expected in the Viral Gastroenteritis Market?
3. What Are the Key Innovations Transforming the Viral Gastroenteritis Industry?
4. Which Region Is Leading the Viral Gastroenteritis Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.